{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T05:24:56Z","timestamp":1788931496602,"version":"build-2803163510"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,6,17]],"date-time":"2022-06-17T00:00:00Z","timestamp":1655424000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,6,17]],"date-time":"2022-06-17T00:00:00Z","timestamp":1655424000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The aim of this work is\u00a0to examine our experience in the use of urea in patients with SIADH. Observational retrospective analysis of 48 patients with SIADH that have been treated with urea in a third-level hospital. Pre-post analysis of serum sodium levels. The 48 patients with SIADH had a median age of 78.5 (range 26\u201397\u00a0years). The serum sodium nadir was 119.8\u2009\u00b1\u20095.0 mmoL\/L and at the beginning of treatment 125.6\u2009\u00b1\u20094.1 mmoL\/L. The patients continued the treatment for a mean time of 2.95\u2009\u00b1\u20096.29\u00a0months, being the treatment still active in 4 patients. In all patients there was an improvement in serum sodium, being the final serum sodium at the end of treatment 134.4\u2009\u00b1\u20094.9 mmoL\/L (p\u2009&lt;\u20090.01). This improvement was observed from the first week. Adverse events were only detected in 2 patients with mild digestive symptomatology and 2 patients refused the treatment due to the low palatability of the urea. There was an economic cost reduction of 87.9% in comparison with treatment with tolvaptan. Urea has shown to be a safe and cost-effective option for the treatment of hyponatremia caused by SIADH.<\/jats:p>","DOI":"10.1038\/s41598-022-14387-4","type":"journal-article","created":{"date-parts":[[2022,6,17]],"date-time":"2022-06-17T17:03:19Z","timestamp":1655485399000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Clinical efficacy of urea treatment in syndrome of inappropriate antidiuretic hormone secretion"],"prefix":"10.1038","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6378-7566","authenticated-orcid":false,"given":"Eva","family":"Perell\u00f3-Camacho","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0202-1265","authenticated-orcid":false,"given":"Francisco J.","family":"Pomares-G\u00f3mez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1188-8191","authenticated-orcid":false,"given":"Luis","family":"L\u00f3pez-Penabad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosa Mar\u00eda","family":"Mirete-L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Rosa","family":"Pinedo-Esteban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Ram\u00f3n","family":"Dom\u00ednguez-Escribano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,6,17]]},"reference":[{"issue":"1","key":"14387_CR1","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1080\/17446651.2019.1556095","volume":"14","author":"A Peri","year":"2019","unstructured":"Peri, A. Management of hyponatremia: causes, clinical aspects, differential diagnosis and treatment. Expert Rev. Endocrinol. Metab. 14(1), 13\u201321. https:\/\/doi.org\/10.1080\/17446651.2019.1556095 (2019).","journal-title":"Expert Rev. Endocrinol. Metab."},{"key":"14387_CR2","doi-asserted-by":"publisher","first-page":"G1","DOI":"10.1007\/s00134-014-3210-2","volume":"170","author":"G Spasovski","year":"2014","unstructured":"Spasovski, G. et al. Clinical practice guideline on diagnosis and treatment of hyponatraemia. Nephrol. Dial Transplant. 170, G1-47. https:\/\/doi.org\/10.1007\/s00134-014-3210-2 (2014).","journal-title":"Nephrol. Dial Transplant."},{"issue":"Suppl 1","key":"14387_CR3","doi-asserted-by":"publisher","first-page":"S5","DOI":"10.1530\/EJE-09-1063","volume":"162","author":"MJ Hannon","year":"2010","unstructured":"Hannon, M. J. & Thompson, C. J. The syndrome of inappropriate antidiuretic hormone: Prevalence, causes and consequences. Eur. J. Endocrinol. 162(Suppl 1), S5-12. https:\/\/doi.org\/10.1530\/EJE-09-1063 (2010).","journal-title":"Eur. J. Endocrinol."},{"issue":"1","key":"14387_CR4","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1053\/j.ajkd.2008.03.004","volume":"52","author":"G Liamis","year":"2008","unstructured":"Liamis, G., Milionis, H. & Elisaf, M. A review of drug-induced hyponatremia. Am. J. Kidney Dis. 52(1), 144\u2013153. https:\/\/doi.org\/10.1053\/j.ajkd.2008.03.004 (2008).","journal-title":"Am. J. Kidney Dis."},{"issue":"4","key":"14387_CR5","doi-asserted-by":"publisher","first-page":"379","DOI":"10.7399\/fh.2014.38.4.1112","volume":"38","author":"I G\u00f3mez-Valbuena","year":"2014","unstructured":"G\u00f3mez-Valbuena, I., Alonso-P\u00e9rez, L., Alioto, D., Ca\u00f1amares-Orbis, I. & Ferrari-Piquero, J. M. Treatment with urea as an alternative to tolvaptan for the syndrome of inappropriate secretion of antidiuretic hormone. Farm. Hosp. 38(4), 379\u2013380. https:\/\/doi.org\/10.7399\/fh.2014.38.4.1112 (2014).","journal-title":"Farm. Hosp."},{"issue":"9","key":"14387_CR6","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1007\/s40618-016-0463-3","volume":"39","author":"M Cuesta","year":"2016","unstructured":"Cuesta, M., Garrahy, A. & Thompson, C. J. SIAD: Practical recommendations for diagnosis and management. J. Endocrinol. Invest. 39(9), 991\u20131001. https:\/\/doi.org\/10.1007\/s40618-016-0463-3 (2016).","journal-title":"J. Endocrinol. Invest."},{"issue":"2","key":"14387_CR7","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1177\/2042018812437561","volume":"3","author":"P Gross","year":"2012","unstructured":"Gross, P. Clinical management of SIADH. Ther. Adv. Endocrinol. Metab. 3(2), 61\u201373. https:\/\/doi.org\/10.1177\/2042018812437561 (2012).","journal-title":"Ther. Adv. Endocrinol. Metab."},{"issue":"10 Suppl 1","key":"14387_CR8","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/j.amjmed.2013.07.006","volume":"126","author":"JG Verbalis","year":"2013","unstructured":"Verbalis, J. G. et al. Diagnosis, evaluation, and treatment of hyponatremia: Expert panel recommendations. Am. J. Med. 126(10 Suppl 1), S1-42. https:\/\/doi.org\/10.1016\/j.amjmed.2013.07.006 (2013).","journal-title":"Am. J. Med."},{"issue":"5","key":"14387_CR9","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1681\/ASN.2016101139","volume":"28","author":"EJ Hoorn","year":"2017","unstructured":"Hoorn, E. J. & Zietse, R. Diagnosis and treatment of hyponatremia: Compilation of the guidelines. J. Am. Soc. Nephrol. 28(5), 1340\u20131349. https:\/\/doi.org\/10.1681\/ASN.2016101139 (2017).","journal-title":"J. Am. Soc. Nephrol."},{"issue":"2","key":"14387_CR10","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.beem.2016.02.004","volume":"30","author":"H Rondon-Berrios","year":"2016","unstructured":"Rondon-Berrios, H. & Berl, T. Vasopressin receptor antagonists: Characteristics and clinical role. Best. Pract. Res. Clin. Endocrinol. Metab. 30(2), 289\u2013303. https:\/\/doi.org\/10.1016\/j.beem.2016.02.004 (2016).","journal-title":"Best. Pract. Res. Clin. Endocrinol. Metab."},{"issue":"11","key":"14387_CR11","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.2215\/CJN.04020318","volume":"13","author":"H Rondon-Berrios","year":"2018","unstructured":"Rondon-Berrios, H. et al. Urea for the treatment of hyponatremia. Clin. J. Am. Soc. Nephrol. 13(11), 1627\u20131632. https:\/\/doi.org\/10.2215\/CJN.04020318 (2018).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"14387_CR12","unstructured":"Drug Safety and Availability [Internet]. U.S. Food & Drug Administration. Silver Spring (MD): U.S. Food & Drug Administration. [cited 2020 May 16]. Available from: http:\/\/www.fda.gov\/Drugs\/DrugSafety\/default.htm."},{"issue":"12","key":"14387_CR13","doi-asserted-by":"publisher","first-page":"2268","DOI":"10.2215\/CJN.00170115","volume":"10","author":"H Rondon-Berrios","year":"2015","unstructured":"Rondon-Berrios, H. & Berl, T. Mild chronic hyponatremia in the ambulatory setting: Significance and management. Clin. J. Am. Soc. Nephrol. 10(12), 2268\u20132278 (2015).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"issue":"1\u20132","key":"14387_CR14","doi-asserted-by":"publisher","first-page":"212","DOI":"10.2215\/CJN.00170115","volume":"49","author":"H Rondon-Berrios","year":"2020","unstructured":"Rondon-Berrios, H. Urea for chronic hyponatremia. Blood Purif. 49(1\u20132), 212\u2013218. https:\/\/doi.org\/10.2215\/CJN.00170115 (2020).","journal-title":"Blood Purif."},{"issue":"5","key":"14387_CR15","doi-asserted-by":"publisher","first-page":"R184","DOI":"10.1186\/cc9292","volume":"14","author":"G Decaux","year":"2010","unstructured":"Decaux, G., Andres, C., Gankam Kengne, F. & Soupart, A. Treatment of euvolemic hyponatremia in the intensive care unit by urea. Crit. Care. 14(5), R184. https:\/\/doi.org\/10.1186\/cc9292 (2010).","journal-title":"Crit. Care."},{"issue":"9","key":"14387_CR16","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1016\/j.endonu.2014.04.006","volume":"61","author":"O De Sol\u00e0-Morales","year":"2014","unstructured":"De Sol\u00e0-Morales, O. & Riera, M. Urea for management of the syndrome of inappropriate secretion of ADH: A systematic review. Endocrinol. Nutr. 61(9), 486\u2013492. https:\/\/doi.org\/10.1016\/j.endonu.2014.04.006 (2014).","journal-title":"Endocrinol. Nutr."},{"issue":"6","key":"14387_CR17","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1111\/cen.13966","volume":"90","author":"A Nervo","year":"2019","unstructured":"Nervo, A. et al. Urea in cancer patients with chronic SIAD-induced hyponatremia: Old drug, new evidence. Clin. Endocrinol. (Oxf). 90(6), 842\u2013848. https:\/\/doi.org\/10.1111\/cen.13966 (2019).","journal-title":"Clin. Endocrinol. (Oxf)."},{"issue":"1","key":"14387_CR18","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/0002-9343(80)90506-9","volume":"69","author":"G Decaux","year":"1980","unstructured":"Decaux, G., Brimioulle, S., Genette, F. & Mockel, J. Treatment of the syndrome of inappropriate secretion of antidiuretic hormone by urea. Am. J. Med. 69(1), 99\u2013106. https:\/\/doi.org\/10.1016\/0002-9343(80)90506-9 (1980).","journal-title":"Am. J. Med."},{"key":"14387_CR19","doi-asserted-by":"publisher","first-page":"175883591987772","DOI":"10.1177\/1758835919877725","volume":"11","author":"R Berardi","year":"2019","unstructured":"Berardi, R. et al. Syndrome of inappropriate anti-diuretic hormone secretion in cancer patients: Results of the first multicenter Italian study. Ther. Adv. Med. Oncol. 11, 1758835919877725. https:\/\/doi.org\/10.1177\/1758835919877725 (2019).","journal-title":"Ther. Adv. Med. Oncol."},{"issue":"5","key":"14387_CR20","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1016\/0002-9343(67)90096-4","volume":"42","author":"FC Bartter","year":"1967","unstructured":"Bartter, F. C. & Schwartz, W. B. The syndrome of inappropriate secretion of antidiuretic hormone. Am. J. Med. 42(5), 790\u2013806. https:\/\/doi.org\/10.1016\/0002-9343(67)90096-4 (1967).","journal-title":"Am. J. Med."},{"issue":"2","key":"14387_CR21","first-page":"84","volume":"86","author":"J Fogarty","year":"2017","unstructured":"Fogarty, J. & Loughrey, C. Hyponatraemia in hospitalised adults: a guide for the junior doctor. Ulster Med. J. 86(2), 84\u201389 (2017).","journal-title":"Ulster Med. J."},{"issue":"3","key":"14387_CR22","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.3390\/jcm3031043","volume":"3","author":"G Decaux","year":"2014","unstructured":"Decaux, G. et al. Actual therapeutic indication of an old drug: Urea for treatment of severely symptomatic and mild chronic hyponatremia related to SIADH. J. Clin. Med. 3(3), 1043\u20131049. https:\/\/doi.org\/10.3390\/jcm3031043 (2014).","journal-title":"J. Clin. Med."},{"issue":"6299","key":"14387_CR23","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1136\/bmj.283.6299.108","volume":"283","author":"G Decaux","year":"1981","unstructured":"Decaux, G. & Genette, F. Urea for long-term treatment of syndrome of inappropriate secretion of antidiuretic hormone. Br. Med. J. (Clin. Res. Ed). 283(6299), 1081\u20131083. https:\/\/doi.org\/10.1136\/bmj.283.6299.108 (1981).","journal-title":"Br. Med. J. (Clin. Res. Ed)."},{"issue":"6","key":"14387_CR24","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1053\/j.ajkd.2017.12.002","volume":"71","author":"JH Morris","year":"2018","unstructured":"Morris, J. H. et al. Rapidity of correction of hyponatremia due to syndrome of inappropriate secretion of antidiuretic hormone following tolvaptan. Am. J. Kidney Dis. 71(6), 772\u2013782. https:\/\/doi.org\/10.1053\/j.ajkd.2017.12.002 (2018).","journal-title":"Am. J. Kidney Dis."},{"issue":"5","key":"14387_CR25","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1007\/s00228-020-02848-6","volume":"76","author":"Y Kim","year":"2020","unstructured":"Kim, Y., Lee, N., Lee, K. E. & Gwak, H. S. Risk factors for sodium overcorrection in non-hypovolemic hyponatremia patients treated with tolvaptan. Eur. J. Clin. Pharmacol. 76(5), 723\u2013729. https:\/\/doi.org\/10.1007\/s00228-020-02848-6 (2020).","journal-title":"Eur. J. Clin. Pharmacol."},{"issue":"1","key":"14387_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/2110-5820-2-13","volume":"2","author":"C Pierrakos","year":"2012","unstructured":"Pierrakos, C., Taccone, F. S., Decaux, G., Vincent, J. L. & Brimioulle, S. Urea for treatment of acute SIADH in patients with subarachnoid hemorrhage: A single-center experience. Ann. Intensive Care. 2(1), 1. https:\/\/doi.org\/10.1186\/2110-5820-2-13 (2012).","journal-title":"Ann. Intensive Care."},{"issue":"7","key":"14387_CR27","doi-asserted-by":"publisher","first-page":"1856","DOI":"10.1093\/ndt\/gfm138","volume":"22","author":"A Soupart","year":"2007","unstructured":"Soupart, A., Schro\u00ebder, B. & Decaux, G. Treatment of hyponatraemia by urea decreases risks of brain complications in rats: Brain osmolyte contents analysis. Nephrol. Dial. Transplant. 22(7), 1856\u20131863. https:\/\/doi.org\/10.1093\/ndt\/gfm138 (2007).","journal-title":"Nephrol. Dial. Transplant."},{"issue":"6","key":"14387_CR28","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1111\/joim.12532","volume":"280","author":"B Winzeler","year":"2016","unstructured":"Winzeler, B. et al. Predictors of nonresponse to fluid restriction in hyponatraemia due to the syndrome of inappropriate antidiuresis. J. Intern. Med. 280(6), 609\u2013617. https:\/\/doi.org\/10.1111\/joim.12532 (2016).","journal-title":"J. Intern. Med."},{"issue":"4","key":"14387_CR29","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1001\/jama.1982.03320290017021","volume":"247","author":"G Decaux","year":"1982","unstructured":"Decaux, G., Unger, J., Brimioulle, S. & Mockel, J. Hyponatremia in the syndrome of inappropriate secretion of antidiuretic hormone: Rapid correction with urea, sodium chloride, and water restriction therapy. JAMA 247(4), 471\u2013474 (1982).","journal-title":"JAMA"},{"issue":"3","key":"14387_CR30","first-page":"125","volume":"78","author":"J Woudstra","year":"2020","unstructured":"Woudstra, J., De Boer, M. P., Hempenius, L. & Van Roon, E. N. Urea for hyponatraemia due to the syndrome of inappropriate antidiuretic hormone secretion. Neth. J. Med. 78(3), 125\u2013132 (2020).","journal-title":"Neth. J. Med."},{"issue":"10","key":"14387_CR31","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.3390\/jcm8101511","volume":"8","author":"G Decaux","year":"2019","unstructured":"Decaux, G. & Musch, W. Estimated daily urine volume and solute excretion from spot urine samples to guide the therapy of hyponatremia in SIADH. J. Clin. Med. 8(10), 1511. https:\/\/doi.org\/10.3390\/jcm8101511 (2019).","journal-title":"J. Clin. Med."},{"key":"14387_CR32","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.ejim.2017.09.024","volume":"48","author":"G Decaux","year":"2018","unstructured":"Decaux, G. et al. Mild water restriction with or without urea for the longterm treatment of syndrome of inappropriate antidiuretic hormone secretion (SIADH): Can urine osmolality help the choice?. Eur. J. Intern. Med. 48, 89\u201393. https:\/\/doi.org\/10.1016\/j.ejim.2017.09.024 (2018).","journal-title":"Eur. J. Intern. Med."},{"issue":"3","key":"14387_CR33","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1159\/000336716","volume":"35","author":"J Coussement","year":"2012","unstructured":"Coussement, J. et al. Treatment of the syndrome of inappropriate secretion of antidiuretic hormone with urea in critically ill patients. Am. J. Nephrol. 35(3), 265\u2013270. https:\/\/doi.org\/10.1159\/000336716 (2012).","journal-title":"Am. J. Nephrol."},{"issue":"1","key":"14387_CR34","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/0167-5273(87)90040-4","volume":"17","author":"P Cauchie","year":"1987","unstructured":"Cauchie, P., Vincken, W. & Decaux, G. Urea treatment for water retention in hyponatremic congestive heart failure. Int. J. Cardiol. 17(1), 102\u2013104. https:\/\/doi.org\/10.1016\/0167-5273(87)90040-4 (1987).","journal-title":"Int. J. Cardiol."},{"key":"14387_CR35","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.4088\/jcp.v66n1105","volume":"66","author":"A Verhoeven","year":"2005","unstructured":"Verhoeven, A., Musch, W. & Decaux, G. Treatment of the polydipsia-hyponatremia syndrome with urea. J. Clin. Psychiatry. 66, 1372\u20131375. https:\/\/doi.org\/10.4088\/jcp.v66n1105 (2005).","journal-title":"J. Clin. Psychiatry."},{"issue":"9","key":"14387_CR36","doi-asserted-by":"publisher","first-page":"2839","DOI":"10.1093\/ndt\/gfq324","volume":"25","author":"EN Levtchenko","year":"2010","unstructured":"Levtchenko, E. N. & Monnens, L. A. Nephrogenic syndrome of inappropriate antidiuresis. Nephrol. Dial. Transplant. 25(9), 2839\u20132843. https:\/\/doi.org\/10.1093\/ndt\/gfq324 (2010).","journal-title":"Nephrol. Dial. Transplant."},{"key":"14387_CR37","unstructured":"Real Decreto 957\/2020, de 3 de noviembre, por el que se regulan los estudios observacionales con medicamentos de uso humano (Official State Gazette, 310, November 3, 2020, Spain). Available from: https:\/\/boe.es\/diario_boe\/txt.php?id=BOE-A-2020-14960."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-14387-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-14387-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-14387-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,25]],"date-time":"2022-11-25T05:38:57Z","timestamp":1669354737000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-14387-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,17]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["14387"],"URL":"https:\/\/doi.org\/10.1038\/s41598-022-14387-4","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,17]]},"assertion":[{"value":"14 February 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 May 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"10266"}}